50 related articles for article (PubMed ID: 19921106)
1. Risk of subsequent malignancies in primary cutaneous anaplastic large cell lymphoma: a national database study.
Joshi TP; Kunta N; Gupta R
Arch Dermatol Res; 2023 Dec; 316(1):57. PubMed ID: 38141099
[No Abstract] [Full Text] [Related]
2. Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma.
Avallone G; Leo F; Astrua C; Mastorino L; Parente R; Grassi M; Fabrizio R; Ferraris A; Quaglino P; Ribero S
Ital J Dermatol Venerol; 2024 Apr; 159(2):215-216. PubMed ID: 38436616
[No Abstract] [Full Text] [Related]
3. [Primary cutaneous CD30+ ALK(-) anaplastic large cell T-cell lymphoma].
Mühlhoff C; Rübben A; Gassler N; Megahed M
Hautarzt; 2009 Dec; 60(12):954-6. PubMed ID: 19921106
[TBL] [Abstract][Full Text] [Related]
4. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature.
Burg G; Kempf W; Kazakov DV; Dummer R; Frosch PJ; Lange-Ionescu S; Nishikawa T; Kadin ME
Br J Dermatol; 2003 Mar; 148(3):580-6. PubMed ID: 12653754
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
[TBL] [Abstract][Full Text] [Related]
6. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
7. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
9. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
10. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
[TBL] [Abstract][Full Text] [Related]
12. Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.
Beylot-Barry M; Groppi A; Vergier B; Pulford K; Merlio JP
Blood; 1998 Jun; 91(12):4668-76. PubMed ID: 9616164
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Vonderheid EC; Sajjadian A; Kadin ME
J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
